Benefits of ninerafaxstat in non-obstructive hypertrophic cardiomyopathy

Nat Rev Cardiol. 2024 Jun;21(6):357. doi: 10.1038/s41569-024-01032-y.
No abstract available

Publication types

  • Comment

MeSH terms

  • Benzylamines
  • Cardiomyopathy, Hypertrophic* / complications
  • Cardiomyopathy, Hypertrophic* / drug therapy
  • Cardiomyopathy, Hypertrophic* / physiopathology
  • Humans
  • Treatment Outcome
  • Uracil / analogs & derivatives

Substances

  • MYK-461